281 related articles for article (PubMed ID: 10508165)
21. The normal cell cycle activation program is exploited during the infection of quiescent B lymphocytes by Epstein-Barr virus.
Hollyoake M; Stühler A; Farrell P; Gordon J; Sinclair A
Cancer Res; 1995 Nov; 55(21):4784-7. PubMed ID: 7585505
[TBL] [Abstract][Full Text] [Related]
22. Modulation of c-Myc activity and apoptosis in vivo.
Alarcon RM; Rupnow BA; Graeber TG; Knox SJ; Giaccia AJ
Cancer Res; 1996 Oct; 56(19):4315-9. PubMed ID: 8813114
[TBL] [Abstract][Full Text] [Related]
23. Highly controlled heterologous gene expression through combined utilization of the tetracycline-repressible transactivator and the lac repressor.
Hoshikawa Y; Amimoto K; Mizuguchi R; Hatakeyama M
Anal Biochem; 1998 Aug; 261(2):211-8. PubMed ID: 9716424
[TBL] [Abstract][Full Text] [Related]
24. Myc and the cell cycle.
Amati B; Alevizopoulos K; Vlach J
Front Biosci; 1998 Feb; 3():d250-68. PubMed ID: 9468463
[TBL] [Abstract][Full Text] [Related]
25. c-Myc induces apoptosis and cell cycle progression by separable, yet overlapping, pathways.
Packham G; Porter CW; Cleveland JL
Oncogene; 1996 Aug; 13(3):461-9. PubMed ID: 8760287
[TBL] [Abstract][Full Text] [Related]
26. Direct and indirect regulation of cytokine and cell cycle proteins by EBNA-2 during Epstein-Barr virus infection.
Spender LC; Cornish GH; Rowland B; Kempkes B; Farrell PJ
J Virol; 2001 Apr; 75(8):3537-46. PubMed ID: 11264343
[TBL] [Abstract][Full Text] [Related]
27. Myc inhibits p27-induced erythroid differentiation of leukemia cells by repressing erythroid master genes without reversing p27-mediated cell cycle arrest.
Acosta JC; Ferrándiz N; Bretones G; Torrano V; Blanco R; Richard C; O'Connell B; Sedivy J; Delgado MD; León J
Mol Cell Biol; 2008 Dec; 28(24):7286-95. PubMed ID: 18838534
[TBL] [Abstract][Full Text] [Related]
28. c-Myc represses FOXO3a-mediated transcription of the gene encoding the p27(Kip1) cyclin dependent kinase inhibitor.
Chandramohan V; Mineva ND; Burke B; Jeay S; Wu M; Shen J; Yang W; Hann SR; Sonenshein GE
J Cell Biochem; 2008 Aug; 104(6):2091-106. PubMed ID: 18393360
[TBL] [Abstract][Full Text] [Related]
29. Gamma interferon induces expression of Mad1 gene in macrophage, which inhibits colony-stimulating factor-1-dependent mitogenesis.
Dey A; Kim L; Li W
J Cell Biochem; 1999 Feb; 72(2):232-41. PubMed ID: 10022505
[TBL] [Abstract][Full Text] [Related]
30. Density-dependent growth inhibition of fibroblasts ectopically expressing p27(kip1).
Zhang X; Wharton W; Donovan M; Coppola D; Croxton R; Cress WD; Pledger WJ
Mol Biol Cell; 2000 Jun; 11(6):2117-30. PubMed ID: 10848633
[TBL] [Abstract][Full Text] [Related]
31. Mechanism of interleukin-10 inhibition of T-helper cell activation by superantigen at the level of the cell cycle.
Perrin GQ; Johnson HM; Subramaniam PS
Blood; 1999 Jan; 93(1):208-16. PubMed ID: 9864163
[TBL] [Abstract][Full Text] [Related]
32. Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination.
Mateyak MK; Obaya AJ; Adachi S; Sedivy JM
Cell Growth Differ; 1997 Oct; 8(10):1039-48. PubMed ID: 9342182
[TBL] [Abstract][Full Text] [Related]
33. Expression of P27(KIP1) is prognostic and independent of MYCN amplification in human neuroblastoma.
Bergmann E; Wanzel M; Weber A; Shin I; Christiansen H; Eilers M
Int J Cancer; 2001 May; 95(3):176-83. PubMed ID: 11307151
[TBL] [Abstract][Full Text] [Related]
34. MYC can enforce cell cycle transit from G1 to S and G2 to S, but not mitotic cellular division, independent of p27-mediated inihibition of cyclin E/CDK2.
Deb-Basu D; Karlsson A; Li Q; Dang CV; Felsher DW
Cell Cycle; 2006 Jun; 5(12):1348-55. PubMed ID: 16760657
[TBL] [Abstract][Full Text] [Related]
35. Cell cycle activation by c-myc in a burkitt lymphoma model cell line.
Pajic A; Spitkovsky D; Christoph B; Kempkes B; Schuhmacher M; Staege MS; Brielmeier M; Ellwart J; Kohlhuber F; Bornkamm GW; Polack A; Eick D
Int J Cancer; 2000 Sep; 87(6):787-93. PubMed ID: 10956386
[TBL] [Abstract][Full Text] [Related]
36. Complex regulation of cell-cycle inhibitors by Fbxw7 in mouse embryonic fibroblasts.
Masuda K; Ishikawa Y; Onoyama I; Unno M; de Alborán IM; Nakayama KI; Nakayama K
Oncogene; 2010 Mar; 29(12):1798-809. PubMed ID: 20023701
[TBL] [Abstract][Full Text] [Related]
37. Increased expression of cyclin D2 during multiple states of growth arrest in primary and established cells.
Meyyappan M; Wong H; Hull C; Riabowol KT
Mol Cell Biol; 1998 Jun; 18(6):3163-72. PubMed ID: 9584157
[TBL] [Abstract][Full Text] [Related]
38. Hypertrophic growth in cardiac myocytes is mediated by Myc through a Cyclin D2-dependent pathway.
Zhong W; Mao S; Tobis S; Angelis E; Jordan MC; Roos KP; Fishbein MC; de Alborán IM; MacLellan WR
EMBO J; 2006 Aug; 25(16):3869-79. PubMed ID: 16902412
[TBL] [Abstract][Full Text] [Related]
39. Myc and cell cycle control.
Bretones G; Delgado MD; León J
Biochim Biophys Acta; 2015 May; 1849(5):506-16. PubMed ID: 24704206
[TBL] [Abstract][Full Text] [Related]
40. Role of c-myc and p27 in anti-IgM induced B-lymphoma apoptosis.
Scott DW; Donjerković D; Maddox B; Ezhevsky S; Grdina T
Curr Top Microbiol Immunol; 1997; 224():103-12. PubMed ID: 9308233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
